News and Features
Drug companies influence research; they also affect what gets published.
The New Republic strains credibility with its 'Idiocy Watch'—it might want to keep itself in its sights.
Media policy need to change in the digital age—but how?
With developments in the Mumia Abu-Jamal case and Pacifica's re-emergence, the left has a couple of victories under its belt; the Enron scandal develops further.
Organic farming critic Dennis Avery is supported by generous contributions from several chemical companies, all of whom profit from the sale of products prohibited in organic production.
John Stossel has high Q-ratings, so he doesn't have to worry about the rules.
Media consolidation is creeping in slowly while the public’s attention is elsewhere—is it too late to fight back?
Synergy—it's all well and good. But media consolidation's dark side often raises its head.
For three months now, I've been closely following the coverage of September 11 and its aftermath; how well have the media done?
Getting serious about media reform: at a standstill now, the media reform movement's time has come.